InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (35 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
35
T+90 hit rate
33%
T+90 mean return
-11.7%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Anzalone Christopher Richard, Chief Executive Officer. Director active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 60 disclosures have been published. Breakdown: 0 buy · 35 sells. Total volume traded: €27.9m. History available since 20 October 2021. The latest transaction was filed on 2 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations60 total
▼
7,416 shares@ US$65.880.0039% mcap3.4% of flowCommon StockSEC:0001423029-26-000001:0
▼
7,416 shares@ US$65.883.4% of flowCommon StockSEC:0001423029-26-000001
◇
35,181 shares@ US$6.151.5% of flowCommon StockSEC:0001423029-25-000009
◇
35,181 shares@ US$6.150.0017% mcap1.5% of flowCommon StockSEC:0001423029-25-000009:0
◇
16,545 shares@ US$6.150.3% of flowCommon StockSEC:0001423029-25-000009:1
▼
35,181 shares@ US$69.336.3% of flowCommon StockSEC:0001423029-25-000009:2
▼
16,545 shares@ US$68.692.9% of flowCommon StockSEC:0001423029-25-000009:3
▼
3,979 shares@ US$66.671.8% of flowCommon StockSEC:0001423029-25-000007
▼
3,979 shares@ US$66.670.0021% mcap1.8% of flowCommon StockSEC:0001423029-25-000007:0
▼
8,147 shares@ US$68.011.4% of flowCommon StockSEC:0001423029-25-000007:1
▼
1,319 shares@ US$68.480.2% of flowCommon StockSEC:0001423029-25-000007:2
▼
10,012 shares@ US$68.331.8% of flowCommon StockSEC:0001423029-25-000007:3
▼
2,574 shares@ US$68.850.5% of flowCommon StockSEC:0001423029-25-000007:4
▼
46,287 shares@ US$63.5520.4% of flowCommon StockSEC:0001423029-25-000005
▼
46,287 shares@ US$63.550.023% mcap20.4% of flowCommon StockSEC:0001423029-25-000005:0
180,000 shares0Common StockSEC:0001423029-25-000003
180,000 shares0Common StockSEC:0001423029-25-000003:0
▼
100,532 shares@ US$68.6717.8% of flowCommon StockSEC:0001423029-25-000003:1
▼
21,321 shares@ US$69.283.8% of flowCommon StockSEC:0001423029-25-000003:2
▼
8,147 shares@ US$69.961.5% of flowCommon StockSEC:0001423029-25-000003:3
▼
8,416 shares@ US$60.511.3% of flowCommon StockSEC:0001423029-25-000003:4
▼
10,963 shares@ US$61.251.7% of flowCommon StockSEC:0001423029-25-000003:5
▼
14,095 shares@ US$62.122.3% of flowCommon StockSEC:0001423029-25-000003:6
▼
8,476 shares@ US$62.941.4% of flowCommon StockSEC:0001423029-25-000003:7
▼
6,661 shares@ US$64.291.1% of flowCommon StockSEC:0001423029-25-000003:8
25 of 60 declarations
About Anzalone Christopher Richard
Anzalone Christopher Richard is the Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC.
